New York State Common Retirement Fund Immunity Bio, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Immunity Bio, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 19,918 shares of IBRX stock, worth $48,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,918
Previous 44,018
54.75%
Holding current value
$48,201
Previous $278,000
73.38%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding IBRX
# of Institutions
202Shares Held
70MCall Options Held
1.67MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$40.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$27.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$9.31 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$5.44 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $969M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...